Adjunct Faculty
Adjunct faculty typically have an academic or research appointment at another institution and contribute or collaborate with one or more School of Medicine faculty members or programs.
Adjunct rank detailsJason Kwah, MD, MSc
Assistant Professor AdjunctAbout
Research
Publications
2026
Baseline Characteristics of Patients with Asthma Initiating Dupilumab in a Real-World Setting: The REVEAL Registry
Máspero J, Arnaout R, Vargas-Ramírez L, Mobayed H, Mahboub B, Irani C, Bar-Shai A, Koh M, Chao J, Zaghloul S, Kwah J, Dewhurst J, Al-Ahmad M. Baseline Characteristics of Patients with Asthma Initiating Dupilumab in a Real-World Setting: The REVEAL Registry. Advances In Therapy 2026, 1-19. PMID: 42268495, DOI: 10.1007/s12325-026-03623-2.Peer-Reviewed Original ResearchBaseline characteristics of patientsObservational study of patientsBaseline characteristicsCharacteristics of patientsSevere exacerbationsDrivers of type 2 inflammationObservational studyFractional exhaled nitric oxide levelsExhaled nitric oxide levelsFrequent severe exacerbationsEfficacy of dupilumabType 2 inflammatory biomarkersModerate-to-severe asthmaPost-bronchodilator forced expiratory volumeType 2 inflammationClinical practiceReal world clinical practiceBlood eosinophil countHuman monoclonal antibodyStudy of patientsNitric oxide levelsForced expiratory volumeNon-HispanicTobacco useNever smokersPeriprocedural Allergy Evaluation is Safe and Effective to Guide Subsequent Anesthesia Administration
Liao J, Belmont A, Su C, You L, Oh J, Son M, Kwah J. Periprocedural Allergy Evaluation is Safe and Effective to Guide Subsequent Anesthesia Administration. Journal Of Allergy And Clinical Immunology Global 2026, 100747. DOI: 10.1016/j.jacig.2026.100747.Peer-Reviewed Original ResearchRetrospective cohort studyAllergy evaluationHypersensitivity reactionsIndex reactionPerioperative anaphylaxisAllergy testingCohort study of adult patientsRetrospective cohort study of adult patientsPositive testStudy of adult patientsTertiary academic centerSkin test resultsComprehensive allergy evaluationTryptase levelsPatient demographicsAdult patientsPatient cohortNeuromuscular blocking agentsSkin testLocal anestheticsAcademic centersUS guidelinesPatientsAnesthesia administrationBlocking agentsB32-14 Real-world Comparative Effectiveness of Dupilumab vs. Tezepelumab on Asthma Exacerbations: A US Claims Analysis
Mosnaim G, Doherty T, Lipworth B, Drake M, Avella H, Kwah J, Moraco A, Madziva D, Hawaldar K, Petruski-Ivleva N, Yang J, Gandhi A. B32-14 Real-world Comparative Effectiveness of Dupilumab vs. Tezepelumab on Asthma Exacerbations: A US Claims Analysis. American Journal Of Respiratory And Critical Care Medicine 2026, 212: aamag162.454. DOI: 10.1093/ajrccm/aamag162.454.Peer-Reviewed Original ResearchEffects of dupilumabReal-world studyIncidence rate ratiosSystemic corticosteroidsFollow-upAsthma exacerbationsModerate-to-severe asthmaRetrospective claims studyDays post-indexFollow-up timeTreatment of patientsFollow-up periodIncidence of exacerbationsUS administrative claims dataAdministrative claims databaseLung function parametersStandardized mean differenceTherapy discontinuationPotential residual confoundingStudy limitationsExacerbation ratePost-indexEosinophilic phenotypeRetrospective studyDupilumabB32-19 Long-Term Outcomes in Traverse in Patients With Type 2 Asthma Treated With Dupilumab Based on Clinical Remission Status at the End of Quest
Brusselle G, Katial R, Couillard S, Peters A, Canonica W, Changming X, Ledanois O, Kwah J, Lugogo N. B32-19 Long-Term Outcomes in Traverse in Patients With Type 2 Asthma Treated With Dupilumab Based on Clinical Remission Status at the End of Quest. American Journal Of Respiratory And Critical Care Medicine 2026, 212: aamag162.459. DOI: 10.1093/ajrccm/aamag162.459.Peer-Reviewed Original ResearchType 2 asthmaClinical remissionPre-bronchodilator FEV1Remission statusACQ-5Exacerbation ratePre-bronchodilator forced expiratory volumeSustained clinical benefitClinical remission statusTreatment goalsOral corticosteroid useProportion of patientsACQ-5 scoresAdd-on dupilumabLong-term outcomesRelevant treatment goalsEarly disease controlAsthma Control QuestionnairePost Hoc AnalysisPlacebo Q2WCorticosteroid useClinical benefitDupilumabRemissionResults PatientsEvaluating penicillin allergy clinical decision-making tools to enhance penicillin allergy delabeling
Su C, Belmont A, Son M, Liao J, Trubiano J, Kwah J. Evaluating penicillin allergy clinical decision-making tools to enhance penicillin allergy delabeling. Journal Of Allergy And Clinical Immunology Global 2026, 5: 100719. PMID: 42222591, PMCID: PMC13218126, DOI: 10.1016/j.jacig.2026.100719.Peer-Reviewed Original ResearchRetrospective chart reviewSkin test resultsPenicillin allergyFollow-up surveyClinical decision-making toolSkin testRetrospective chart review of patientsNegative skin test resultsChart review of patientsPositive skin test resultsAssociated with adverse outcomesReview of patientsLow-risk featuresNegative predictive valueNegative skin testsPenicillin allergy evaluationClinical decision ruleHealth care systemPenicillin allergy delabelingPenicillin challengePenicillin testingPenicillin useAllergy evaluationFollow-upAdverse outcomesReal-world, long-term effectiveness of dupilumab treatment in patients with severe asthma: 2 years of the ProVENT study
Lommatzsch M, Schmidt O, Timmermann H, Gappa M, Watz H, Kwah J, Ledanois O, Nischan N, Hahn M, Heimann A, Korn S. Real-world, long-term effectiveness of dupilumab treatment in patients with severe asthma: 2 years of the ProVENT study. Respiratory Medicine 2026, 254: 108750. PMID: 41785977, DOI: 10.1016/j.rmed.2026.108750.Peer-Reviewed Original ResearchConceptsEffects of dupilumab treatmentAsthma Control Test scoreDupilumab treatmentSevere asthmaLong-term effectsClinical efficacyLong-term dupilumab treatmentPre-bronchodilator forced expiratory volumeInterim analysisLung functionQuality of lifeAsthma Control Questionnaire scoreClinical asthma remissionAsthma controlEfficacy of dupilumabClinical remission rateAssociated with sustained improvementFractional exhaled nitric oxideMonths of treatmentQuestionnaire overall scoreExhaled Nitric OxideReal-world patientsSerum immunoglobulin EPost-baseline assessmentRandomized Controlled TrialsValidity of PEN-FAST as a clinical decision tool in pregnant patients
You L, Belmont A, Liao J, Su C, Trubiano J, Son M, Burn M, Kwah J. Validity of PEN-FAST as a clinical decision tool in pregnant patients. Journal Of Allergy And Clinical Immunology Global 2026, 5: 100671. PMID: 41852857, PMCID: PMC12993893, DOI: 10.1016/j.jacig.2026.100671.Peer-Reviewed Original ResearchPregnant patientsPenicillin allergyOral challengeGestational ageSkin testLow riskPredictive valueNegative predicative valueNegative predictive valuePenicillin allergy testingAssociated with adverse patient outcomesSevere adverse eventsNegative likelihood ratioArea under the curvePositive predictive valueClinical decision toolClinical decision-making toolImmunology clinicRisk stratificationAdverse eventsAllergy evaluationAllergy testingAdverse patient outcomesPatientsPatient outcomesComparative effectiveness of biologics in lung function improvement among patients with severe asthma: a real-world study
Bourdin A, Canonica G, Virchow J, Borsos K, Stanford R, Ledanois O, Kwah J, Ge W, Huynh L, Duh M, Boca A, Cheng W, Gandhi A. Comparative effectiveness of biologics in lung function improvement among patients with severe asthma: a real-world study. Respiratory Research 2026, 27: 67. PMID: 41639827, PMCID: PMC12903220, DOI: 10.1186/s12931-026-03515-7.Peer-Reviewed Original ResearchLung function improvementInverse probability of treatment weightingPost-index periodSevere asthmaReal-world studyFunctional improvementBaseline characteristicsRetrospective chart review studyDupilumab-treated patientsPost-BD FEV1Inverse probabilityTreated with omalizumabProbability of treatment weightingChart review studyLinear regressionResidual confoundingEffectiveness of biologicsComparative effectiveness dataClinical trialsTreatment weightingExpiratory volumePatientsPpFEV1Biologic initiationClinical practice
2025
Sex-biased Gene Expression Underlies Immune Dysfunction in Asthma
Kay S, Rajeevan H, Son M, Kwah J, Ramirez M, Liu Y, Wang Z, Yan X, Nino G, Britto C, Chupp G, Gomez J. Sex-biased Gene Expression Underlies Immune Dysfunction in Asthma. American Journal Of Respiratory Cell And Molecular Biology 2025, 73: 884-896. PMID: 40587876, PMCID: PMC13050266, DOI: 10.1165/rcmb.2024-0565oc.Peer-Reviewed Original ResearchThis study investigates sex-biased gene expression in asthma, showing that 61 genes differ by sex in adults, influencing immune responses across the lifespan and asthma severity, providing insight into specific disease mechanisms and supporting more personalized approaches to asthma care.High-Risk Penicillin Reaction Flags in the Medical Record
Novotny S, Elmansy L, Kwah J, Liao J, Wong K, Stone C, Belmont A. High-Risk Penicillin Reaction Flags in the Medical Record. JAMA Network Open 2025, 8: e2549081. PMID: 41632130, PMCID: PMC12717615, DOI: 10.1001/jamanetworkopen.2025.49081.Peer-Reviewed Original Research
Academic Achievements & Community Involvement
News
News
- September 03, 2025
Yale Researchers Uncover Biological Differences in Asthma Between Males and Females
- December 14, 2023
Solving the Drug Allergy Puzzle: A Q&A With Ami Belmont
- October 12, 2023
Welcome New Staff, Faculty, Postdocs & Postgrads! (October 2023)
- April 17, 2023
Yale Allergy & Immunology Presents at AAAAI
Get In Touch
Contacts
Email